.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
McKesson
Express Scripts
Harvard Business School
Colorcon
Medtronic
Julphar
Johnson and Johnson
Fish and Richardson
Novartis

Generated: February 21, 2018

Brazil Drug Patents

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
112014005617➤ Sign Up8492386Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
112014005617➤ Sign Up8492386Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
112014006314➤ Sign Up8466159Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
112014006314➤ Sign Up8466159Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
112014006314➤ Sign Up8680106Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
112014006314➤ Sign Up8680106Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
112014005617➤ Sign Up8685984Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
112014005617➤ Sign Up8685984Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
112014007357➤ Sign Up9095559Mar 9, 2032glycerol phenylbutyrateHorizon Theraps IncRAVICTI
112014007357➤ Sign Up9254278Mar 9, 2032glycerol phenylbutyrateHorizon Theraps IncRAVICTI
This preview shows a limited number of results
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Army
McKinsey
QuintilesIMS
Moodys
Citi
UBS
Novartis
Julphar
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot